Home Answers Support Contact Company
40 Years
PATENTS AND TRADEMARKS

PatentsTrademarks
Novinium employees have conceived and developed virtually all of the commercially significant cable rejuvenation technology used around the world over the last 23 years. Since 2002 when the early seeds of Novinium were planted, these same inventors have been continually advancing the state-of-the-art – Safer … Faster … Better. The advanced technologies practiced by Novinium, its partners, and its licensees are Novinium’s exclusive intellectual property and are protected by at least 10 granted or pending patents including, but not limited to, the following published patents, published patent applications, or unpublished applications and the foreign equivalents thereof:

  • Ultrinium™ sustained pressure injection method (U.S. Patent 7,615,247)
  • Ultrinium™ formulation optimization injection method (U.S. Patent 7,611,748)
  • Injection Adaptor (U.S. Patents 7,195,504, 7,538,274 and 7,683,260)
  • Perfectium™ single visit, single switch injection (U.S. Patent 7,353,601)
  • Formulation of Ultrinium™ & Perficio™ components (U.S. Patent 7,658,808, 7,700,871 and other patents pending)
  • Predicting performance of Electrical Power cables (U.S. Patent 7,643,977)
  • N-Rex™ submarine cable injection process (patent pending)
  • N-Ter™ injection or Novinium thermally enhanced rejuvenation (patent pending)
  • Reticular Flash Preventer (RFP) provides safer operation of conventional injection elbows (patent pending)

Copies of the published documents cited above are available from the U.S. Patent and Trademark office. The Novinium commitment to R&D continues and new patented technology will be rolled out as those novel advances are reduced to practice. For inquiries regarding licensing Novinium technology, send your contact information and the nature of your request to .
© 2006 - 2010 Novinium, Inc.
Contact             Site Map             Trademarks             Terms of Use
The Novinium technology described on these pages includes patented and patent pending technologies.